Oncolytics Biotech INC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Oncolytics Biotech Inc. announces its financial results for the year ended December 31, 2024, and provides an update on its clinical development programs and corporate activities.
NASDAQ
Oncolytics Biotech Inc. reports its 2023 financial results, highlighting ongoing clinical trials and strategic developments.